GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Caplin Point Laboratories Ltd (NSE:CAPLIPOINT) » Definitions » PB Ratio

Caplin Point Laboratories (NSE:CAPLIPOINT) PB Ratio : 4.67 (As of Jun. 24, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Caplin Point Laboratories PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-06-24), Caplin Point Laboratories's share price is ₹1423.65. Caplin Point Laboratories's Book Value per Share for the quarter that ended in Mar. 2024 was ₹304.93. Hence, Caplin Point Laboratories's PB Ratio of today is 4.67.

The historical rank and industry rank for Caplin Point Laboratories's PB Ratio or its related term are showing as below:

NSE:CAPLIPOINT' s PB Ratio Range Over the Past 10 Years
Min: 2.01   Med: 4.77   Max: 24.71
Current: 4.66

During the past 13 years, Caplin Point Laboratories's highest PB Ratio was 24.71. The lowest was 2.01. And the median was 4.77.

NSE:CAPLIPOINT's PB Ratio is ranked worse than
81.55% of 954 companies
in the Drug Manufacturers industry
Industry Median: 1.895 vs NSE:CAPLIPOINT: 4.66

During the past 12 months, Caplin Point Laboratories's average Book Value Per Share Growth Rate was 23.10% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 27.60% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 30.60% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 45.80% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Caplin Point Laboratories was 67.00% per year. The lowest was 10.40% per year. And the median was 37.95% per year.

Back to Basics: PB Ratio


Caplin Point Laboratories PB Ratio Historical Data

The historical data trend for Caplin Point Laboratories's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Caplin Point Laboratories PB Ratio Chart

Caplin Point Laboratories Annual Data
Trend Jun15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.45 2.75 3.46 2.41 4.31

Caplin Point Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.41 - 3.78 - 4.31

Competitive Comparison of Caplin Point Laboratories's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Caplin Point Laboratories's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Caplin Point Laboratories's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Caplin Point Laboratories's PB Ratio distribution charts can be found below:

* The bar in red indicates where Caplin Point Laboratories's PB Ratio falls into.



Caplin Point Laboratories PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Caplin Point Laboratories's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2024)
=1423.65/304.931
=4.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Caplin Point Laboratories  (NSE:CAPLIPOINT) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Caplin Point Laboratories PB Ratio Related Terms

Thank you for viewing the detailed overview of Caplin Point Laboratories's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Caplin Point Laboratories (NSE:CAPLIPOINT) Business Description

Traded in Other Exchanges
Address
Ashvich Tower, Developed Plots Industrial Estate, No. 3, 3rd Floor, Perungudi, Chennai, TN, IND, 600 096
Caplin Point Laboratories Ltd is the India-based pharmaceutical company. It is engaged in the manufacturing and marketing of pharmaceutical products. The company's key products include tablets, capsules, liquid orals, dry powder, soft gels, penems injections, suppositories. It also provides pharmaceutical formulations in specialized injectable dosage forms and Ophthalmic drops. The business of the company is organized into the following product segments, Antibiotics, Nsaids, Ophthalmics, Pain Management, and Antiulcers. Its products have a presence in the Latin American and African markets.

Caplin Point Laboratories (NSE:CAPLIPOINT) Headlines

No Headlines